Showing results (4551-4560 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|October 25, 2012
Heme Oxygenase-1 and breast cancer resistance protein protect against heme-induced toxicityFrank A D T G Wagener, Anita C A Dankers, Frank van Summeren, et al.Current Pharmaceutical Design|August 17, 2012
Mechanisms of β-lactam resistance among Pseudomonas aeruginosaDaniel J Wolter, Philip D ListerCurrent Pharmaceutical Design|May 4, 2023
Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Fei Jin Sheng Formula in the Treatment of Lung CancerYun-Chao Zhang, Wen-Cang Gao, Wei-Jian Chen, et al.Current Pharmaceutical Design|January 31, 2015
Treating cancer and no-cancer pain in older and oldest old patientsG Colloca, F Lattanzio, L Balducci, et al.Current Pharmaceutical Design|July 1, 2014
Telomere maintenance mechanisms in cancer: clinical implicationsRoger R ReddelCurrent Pharmaceutical Design|July 1, 2014
Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapyZachary Crees, Jennifer Girard, Zechary Rios, et al.Current Pharmaceutical Design|July 1, 2014
Telomere-dependent genomic integrity: evolution of the fusion-bridge-breakage cycle conceptPurificacion Feijoo, Daniel Dominguez, Laura Tusell, et al.Current Pharmaceutical Design|July 27, 2012
Protein kinase C-theta inhibitors: a novel therapy for inflammatory disordersSukhvir Chand, Nisha Mehta, Malkeet Singh Bahia, et al.Current Pharmaceutical Design|July 1, 2020
Phytosterols: Targeting Neuroinflammation in NeurodegenerationRaju Dash, Sarmistha Mitra, Md Chayan Ali, et al.Current Pharmaceutical Design|July 3, 2020
Moxifloxacin-Loaded Lipidic Nanoparticles for Antimicrobial EfficacyMohammad Darvishi, Shahrzad Farahani, Azadeh HaeriPageof 1,008